ApoE-4 and age at onset of Alzheimer's disease: the NIMH genetics initiative

Neurology
D BlackerR Tanzi

Abstract

To explore the impact of apoE-4 on Alzheimer's disease (AD) and its age at onset. A genetic linkage study using affected relative pairs, predominantly siblings. Three academic medical centers ascertained subjects from memory disorder clinics, nursing homes, and the local community. 310 families including 679 subjects with AD by NINCDS/ADRDA and/or Khachaturian criteria and 231 unaffected subjects. ApoE genotype. ANALYTIC METHODS: Association, affected pedigree member, sibling pair, and lod score analyses. ApoE-4 was strongly associated with AD in this sample (allele frequency = 0.46 vs. 0.14 in controls, p < 0.000001). Results of lod score, affected pedigree member analysis, and sib-pair analysis also supported apoE-4 as a risk factor for AD. When the sample was stratified on family mean age at onset, the risk conferred by apoE-4 was most marked in the 61 to 65 age group. Individuals with two copies of apoE-4 had a significantly lower age at onset than those with one or no copies (66.4 vs. 72.0, p < 0.001), but individuals with one copy did not differ from those with none. Within families, the individual with the earliest age at onset had, on average, significantly more apoE-4 alleles (p < 0.0001) than the individual with the l...Continue Reading

Associated Clinical Trials

Citations

Oct 15, 2008·Archives of Neurology·Barbara A J SchafferDaniel H Geschwind
Jan 11, 2012·Archives of Neurology·Denise HeadJohn C Morris
Oct 20, 1998·Journal of Neuroscience Research·M Michikawa, K Yanagisawa
Oct 31, 2002·Human Psychopharmacology·Kurt Heininger
Mar 15, 2000·Annals of Neurology·R E Tanzi
Sep 25, 2004·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Dimitrios AvramopoulosSusan S Bassett
Jul 10, 2001·Genetic Epidemiology·N Ertekin-TanerS G Younkin
Oct 23, 2002·Journal of Neuroscience Research·Bruce Teter, J Wesson Ashford
Jan 9, 2010·Journal of Neural Transmission·Alessandra BizzarroC Masullo
Oct 3, 2008·Neurogenetics·Brit-Maren M SchjeideLars Bertram
Feb 26, 2010·Neurogenetics·Margaret Daniele FallinDimitrios Avramopoulos
Aug 19, 2008·Cellular and Molecular Neurobiology·Ji-Liang HuYan-Jun Zeng
Mar 20, 2002·Current Neurology and Neuroscience Reports·L Bertram, R E Tanzi
Jul 10, 2012·Current Neurology and Neuroscience Reports·Jill S Goldman
Jan 10, 2008·Journal of Molecular Neuroscience : MN·Binbin WangXu Ma
Jun 24, 2004·Neurobiology of Aging·Beatrice ArosioMario Clerici
Jul 4, 2006·NeuroRx : the Journal of the American Society for Experimental NeuroTherapeutics·Stephen D GinsbergElliott J Mufson
Nov 6, 2002·Journal of the Neurological Sciences·S SallowayE Stopa
Oct 9, 2001·Mechanisms of Ageing and Development·S SorbiB Nacmias
Apr 27, 2000·Neuroscience and Biobehavioral Reviews·A Collie, P Maruff
Jul 11, 2001·Neurobiology of Aging·M SampietroC Vergani
Jan 5, 2002·Neurobiology of Aging·R T PerryR C Go
Jan 8, 1999·Neurobiology of Aging·J D SmithJ A Levin
Oct 28, 1999·Neurobiology of Aging·S Y Guénette, R E Tanzi
Oct 5, 2001·Neuroscience Letters·S E Poduslo, X Yin
Apr 15, 1999·Neuroscience Letters·F Wavrant-DeVrièzeJ Hardy
Jul 27, 2001·Current Opinion in Chemical Biology·P A Whittaker
Jun 18, 2002·Ageing Research Reviews·Jonathan D Smith
May 24, 2008·International Psychogeriatrics·Constantine G LyketsosPeter P Zandi
May 19, 2004·Journal of the International Neuropsychological Society : JINS·James A LevyTrey Sunderland
Jan 20, 2005·Neuropsychology·Ira DriscollMelissa J Guynn
Sep 22, 2010·Psychology and Aging·Keith A HutchisonJanet M Ducheck

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: APOE

Apolipoprotein E (APOE) polymorphic alleles are major genetic risk factors for Alzheimer's disease. Discover the latest research on APOE and other genetic determinants of Alzheimer's disease here.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.